WCM
IDXX icon

Winton Capital Management’s Idexx Laboratories IDXX Stock Holding History

Winton Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		$15.5M Buy
255,576
+185,372
+264% +$11M 0.11% 294
2013
Q4 		$3.73M Buy
+70,204
New +$3.7M 0.03% 398
2013
Q3 		– Sell
-17,166
Closed -$770K – 683
2013
Q2 		$770K Buy
+17,166
New +$750K 0.01% 548

Other funds holding IDXX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.43B AUM 18.44% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Winton Capital Management's IDXX Position: Q1 2014 in Review

Winton Capital Management increased its Idexx Laboratories (IDXX) stake by 264% in Q1 2014, buying an estimated $11M and bringing the position to 255,576 shares worth $15.5M. The position accounts for 0.11% of the portfolio, ranked #294.

Winton Capital Management first reported a position in IDXX in Q2 2013 and has held it in 3 quarters since. 314 funds tracked by Wall St. Rank hold IDXX as of Q1 2014.

  • Winton Capital Management held 255,576 shares of Idexx Laboratories worth $15.5M as of Q1 2014.
  • Winton Capital Management bought 185,372 Idexx Laboratories shares in Q1 2014, an estimated $11M.
  • Idexx Laboratories made up 0.11% of Winton Capital Management's portfolio in Q1 2014, its #294 holding.
  • Winton Capital Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 3 quarters since.
  • 314 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2014.

Based on Winton Capital Management's 13F filing for Q1 2014, filed 1 May 2014.